IHL-216A - What happened to this?
seemed like a promising market with a lot of media focusing on concussions.
Haven’t heard anything since, except OSA, acquisition of patents and the switch to psychedelics and clarion?
Ann: IHL-216A Preclinical Study Results, page-42
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)